15 March 2014 - Public health experts say effective new drugs to treat hepatitis C should be subsidised in Australia to avert a looming strain on the national health system.

Australians who contracted hepatitis C decades ago are only now starting to develop terminal liver disease at an alarming rate.

More than half of Australia's 250,000 hepatitis C sufferers are baby boomers who contracted the virus back in the 1960s and 1970s, when experimental drug taking was rampant.

For more details, go to: http://www.abc.net.au/news/2014-03-15/australia-urged-to-subsidise-new-hepatitis-c-drugs/5323254